OncoConnect is a “co-founded” venture of the HCI Startup Studio, operating in the highly specialized Digital Oncology sector. Its strategic mandate is to provide oncologists in Tunisia and the Maghreb with critical, real-time clinical decision support. It functions as a sophisticated AI platform connecting doctors and the pharmaceutical industry, exemplifying Tunisia’s growing capacity to deliver effective, scalable solutions for oncology and HealthTech.

Solution in Action The solution is an AI-powered digital assistant designed for and by oncologists. The platform addresses the critical need for access to updated protocols by providing healthcare professionals with instant therapeutic recommendations and real-time data access, streamlining clinical decision-making and improving patient care.

Strategic Positioning & Model OncoConnect is the flagship case study of HCI’s “Clinical-Pull” methodology, which is executed through our Innovation Process with Doctors. Rather than pushing technology onto clinicians, this venture was co-created with oncologists to solve their specific, validated problems. The venture was recently featured in the Startup Valley at the Innovation Galaxy at ICCO 2025, a premier event for connected oncology, highlighting its market readiness and clinical relevance.

Ecosystem & Key Partners

• HealthCare Innovation (HCI): The “co-foundation” partner, providing operational, strategic, and financial resources via the HCI Startup Studio.
• Clinical Partners: A network of oncologists and medical professionals who serve as the co-creators, validators, and end-users of the platform.